These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25657978)

  • 21. Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression.
    Chakera A; MacEwen C; Bellur SS; Chompuk LO; Lunn D; Roberts ISD
    J Nephrol; 2016 Jun; 29(3):367-375. PubMed ID: 26318019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
    Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
    Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biopsy timing and Oxford classification variables in childhood/adolescent IgA nephropathy.
    Shima Y; Nakanishi K; Hama T; Sato M; Mukaiyama H; Togawa H; Tanaka R; Kaito H; Nozu K; Iijima K; Yoshikawa N
    Pediatr Nephrol; 2015 Feb; 30(2):293-9. PubMed ID: 24912604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal Outcomes in Brazilian Patients with Immunoglobulin A Nephropathy and Cellular Crescentic Lesions.
    Neves PDMM; Pinheiro RBB; Dias CB; Yu L; Testagrossa LA; Cavalcante LB; Malheiros DMAC; Jorge LB; Woronik V
    Kidney Blood Press Res; 2020; 45(3):431-441. PubMed ID: 32299081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies.
    El Karoui K; Hill GS; Karras A; Moulonguet L; Caudwell V; Loupy A; Bruneval P; Jacquot C; Nochy D
    Kidney Int; 2011 Mar; 79(6):643-654. PubMed ID: 21178978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive evaluation of the significance of immunofluorescent findings on clinicopathological features in IgA nephropathy.
    Katafuchi R; Nagae H; Masutani K; Tsuruya K; Mitsuiki K
    Clin Exp Nephrol; 2019 Feb; 23(2):169-181. PubMed ID: 30066158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis.
    Xu K; Zhang L; Ding J; Wang S; Su B; Xiao H; Wang F; Zhong X; Li Y
    J Nephrol; 2018 Apr; 31(2):279-286. PubMed ID: 29185209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis.
    Lv J; Shi S; Xu D; Zhang H; Troyanov S; Cattran DC; Wang H
    Am J Kidney Dis; 2013 Nov; 62(5):891-9. PubMed ID: 23820066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Added Value of Crescents on Oxford Classification Score in Risk Stratification of End-stage Kidney Disease in Patients with IgA Nephropathy.
    Ossareh S; Nazemzadeh N; Asgari M; Bagherzadegan H; Afghahi H
    Iran J Kidney Dis; 2022 Mar; 16(2):115-124. PubMed ID: 35489080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of immunostaining findings with demographic data and variables of Oxford classification in IgA nephropathy.
    Nasri H; Sajjadieh S; Mardani S; Momeni A; Merikhi A; Madihi Y; Ghiessari A; Emami Naieni A
    J Nephropathol; 2013 Jul; 2(3):190-5. PubMed ID: 24475448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinicopathological analysis of IgA nephropathy with crescentic formation in childhood].
    Yao Y; Liu JC; Xiao HJ; Huang JP; Yang JY
    Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):412-6. PubMed ID: 15265422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 30-year follow-up study of IgA nephritis in a Southeast Asian population: an evaluation of the Oxford histological classification
.
    Woo KT; Lim CC; Foo MW; Loh HL; Jin AZ; Chin YM; Choo JC; Tan PH; Chow KY; Choong LH; Tan HK; Wong KS; Chan CM
    Clin Nephrol; 2016 Nov; 86 (2016)(11):270-278. PubMed ID: 27641054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification.
    Shi SF; Wang SX; Jiang L; Lv JC; Liu LJ; Chen YQ; Zhu SN; Liu G; Zou WZ; Zhang H; Wang HY
    Clin J Am Soc Nephrol; 2011 Sep; 6(9):2175-84. PubMed ID: 21852672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgA nephropathy: an update.
    Soares MF; Roberts IS
    Curr Opin Nephrol Hypertens; 2017 May; 26(3):165-171. PubMed ID: 28221174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Oxford classification of IgA nephropathy: a retrospective analysis.
    Yau T; Korbet SM; Schwartz MM; Cimbaluk DJ
    Am J Nephrol; 2011; 34(5):435-44. PubMed ID: 21968096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort.
    Bellur SS; Roberts ISD; Troyanov S; Royal V; Coppo R; Cook HT; Cattran D; Arce Terroba Y; Asunis AM; Bajema I; Bertoni E; Bruijn JA; Cannata-Ortiz P; Casartelli D; Maria Di Palma A; Ferrario F; Fortunato M; Furci L; Gakiopoulou H; Galesic Ljubanovic D; Giannakakis K; Gomà M; Gröne HJ; Gutiérrez E; Asma Haider S; Honsova E; Ioachim E; Karkoszka H; Kipgen D; Maldyk J; Mazzucco G; Orhan D; Ozluk Y; Pantzaki A; Perkowska-Ptasinska A; Riispere Z; Soderberg MP; Steenbergen E; Stoppacciaro A; Sundelin Von Feilitzen B; Tardanico R
    Nephrol Dial Transplant; 2019 Oct; 34(10):1681-1690. PubMed ID: 30561721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and pathological features of immunoglobulin A nephropathy patients with nephrotic syndrome.
    Han X; Xiao Y; Tang Y; Zheng X; Anwar M; Qin W
    Clin Exp Med; 2019 Nov; 19(4):479-486. PubMed ID: 31542837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxford classification of immunoglobulin A nephropathy: an update.
    Roberts IS
    Curr Opin Nephrol Hypertens; 2013 May; 22(3):281-6. PubMed ID: 23518465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the Oxford classification of IgA nephropathy.
    Herzenberg AM; Fogo AB; Reich HN; Troyanov S; Bavbek N; Massat AE; Hunley TE; Hladunewich MA; Julian BA; Fervenza FC; Cattran DC
    Kidney Int; 2011 Aug; 80(3):310-7. PubMed ID: 21544062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxford classification of IgA nephropathy and C4d deposition; correlation and its implication.
    Rath A; Tewari R; Mendonca S; Badwal S; Nijhawan VS
    J Nephropharmacol; 2016; 5(2):75-79. PubMed ID: 28197507
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.